Literature DB >> 28785922

Characterization of surface antigens of reticulated immature platelets.

Adi Lador1, Dorit Leshem-Lev2, Galia Spectre3, Aryeh Abelow1, Ran Kornowski1, Eli I Lev4.   

Abstract

Reticulated platelets (RPs) are immature platelets with high dense granules content and a residual amount of megakaryocyte-derived of mRNA. Increased level of RPs has been found to be an independent predictor of cardiovascular ischemic events, and has been associated with impaired response to various anti-platelet drugs. The study aimed to characterize and compare the surface antigenic properties of reticulated versus mature platelets. Platelets from healthy individuals and diabetic patients were tested at rest and after activation with adenosine diphosphate (ADP). For each patient, we calculated the proportion of RPs and mature platelets using flow cytometry analysis with thiazole orange staining (for RPs) and CD42b platelet-specific antibody. We also tested the surface expression of P-selectin and Annexin V, by double staining flow cytometry in RPs versus mature platelets. A total of 20 subjects were recruited (10 healthy individuals, 10 diabetics). Activation with ADP did not cause a significant change in the proportion of RPs. Following activation, RPs demonstrated a significant increase in the expression of both P-selectin and Annexin V, while mature platelets exhibited a non-significant increase in both markers. These findings were consistent in both healthy subjects and patients with diabetes. In conclusion, RPs have a significantly higher capacity to increase the expression of platelet activation markers compared with mature platelets.

Entities:  

Keywords:  Immature platelets; Platelets turnover; Reticulated platelets; Surface antigens

Mesh:

Substances:

Year:  2017        PMID: 28785922     DOI: 10.1007/s11239-017-1533-x

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  20 in total

1.  Immature platelet fraction (IPF) determined with an automated method predicts clopidogrel hyporesponsiveness.

Authors:  Homam Ibrahim; Srinivas Nadipalli; Timothy DeLao; Sasidhar Guthikonda; Neal S Kleiman
Journal:  J Thromb Thrombolysis       Date:  2012-02       Impact factor: 2.300

Review 2.  "Message in the platelet"--more than just vestigial mRNA!

Authors:  Paul Harrison; Alison H Goodall
Journal:  Platelets       Date:  2008-09       Impact factor: 3.862

Review 3.  Platelet miRNAs and cardiovascular diseases.

Authors:  Eduardo Fuentes; Iván Palomo; Marcelo Alarcón
Journal:  Life Sci       Date:  2015-05-20       Impact factor: 5.037

4.  Association of immature platelets with adverse cardiovascular outcomes.

Authors:  Homam Ibrahim; Robert C Schutt; Bashar Hannawi; Timothy DeLao; Colin M Barker; Neal S Kleiman
Journal:  J Am Coll Cardiol       Date:  2014-11-10       Impact factor: 24.094

5.  Comparison of Immature Platelet Count to Established Predictors of Platelet Reactivity During Thienopyridine Therapy.

Authors:  Christian Stratz; Timo Bömicke; Iris Younas; Anja Kittel; Michael Amann; Christian M Valina; Thomas Nührenberg; Dietmar Trenk; Franz-Josef Neumann; Willibald Hochholzer
Journal:  J Am Coll Cardiol       Date:  2016-07-19       Impact factor: 24.094

Review 6.  Flow cytometric measurement of platelet function and reticulated platelets.

Authors:  K A Ault
Journal:  Ann N Y Acad Sci       Date:  1993-03-20       Impact factor: 5.691

7.  Clopidogrel non-responsiveness and risk of cardiovascular morbidity. An updated meta-analysis.

Authors:  Francesco Sofi; Rossella Marcucci; Anna Maria Gori; Betti Giusti; Rosanna Abbate; Gian Franco Gensini
Journal:  Thromb Haemost       Date:  2010-02-02       Impact factor: 5.249

8.  Impact of immature platelets on platelet response to ticagrelor and prasugrel in patients with acute coronary syndrome.

Authors:  Isabell Bernlochner; Alexander Goedel; Conny Plischke; Stefanie Schüpke; Bernhard Haller; Christoph Schulz; Katharina Mayer; Tanja Morath; Siegmund Braun; Heribert Schunkert; Wolfgang Siess; Adnan Kastrati; Karl-Ludwig Laugwitz
Journal:  Eur Heart J       Date:  2015-07-27       Impact factor: 29.983

9.  Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease.

Authors:  Sasidhar Guthikonda; Carlos L Alviar; Muthiah Vaduganathan; Mehmet Arikan; Armando Tellez; Timothy DeLao; Juan F Granada; Jing-Fei Dong; Neal S Kleiman; Eli I Lev
Journal:  J Am Coll Cardiol       Date:  2008-08-26       Impact factor: 24.094

Review 10.  Platelets miRNA as a Prediction Marker of Thrombotic Episodes.

Authors:  Michal Bijak; Malgorzata Dzieciol; Joanna Rywaniak; Joanna Saluk; Marzenna Zielinska
Journal:  Dis Markers       Date:  2016-11-30       Impact factor: 3.434

View more
  4 in total

1.  Proteome and functional decline as platelets age in the circulation.

Authors:  Harriet E Allan; Melissa A Hayman; Simone Marcone; Melissa V Chan; Matthew L Edin; Tania Maffucci; Abhishek Joshi; Laura Menke; Marilena Crescente; Manuel Mayr; Darryl C Zeldin; Paul C Armstrong; Timothy D Warner
Journal:  J Thromb Haemost       Date:  2021-08-27       Impact factor: 16.036

Review 2.  Current Controversy on Platelets and Patent Ductus Arteriosus Closure in Preterm Infants.

Authors:  Hannes Sallmon; Natalie Timme; Begüm Atasay; Ömer Erdeve; Georg Hansmann; Yogen Singh; Sven C Weber; Elaine L Shelton
Journal:  Front Pediatr       Date:  2021-02-25       Impact factor: 3.418

Review 3.  Hematopoietic responses to SARS-CoV-2 infection.

Authors:  Shokrollah Elahi
Journal:  Cell Mol Life Sci       Date:  2022-03-13       Impact factor: 9.207

Review 4.  Immune-Mediated Platelet Activation in COVID-19 and Vaccine-Induced Immune Thrombotic Thrombocytopenia.

Authors:  Günalp Uzun; Lisann Pelzl; Anurag Singh; Tamam Bakchoul
Journal:  Front Immunol       Date:  2022-02-22       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.